99-32332. Notice Pursuant to the National Cooperative Research and Production Act of 1993Advanced Technology Program: Microfluidics Device for Diagnosis of Nosocomial Agents MeDiNA

[Federal Register Volume 64, Number 239 (Tuesday, December 14, 1999)]
[Notices]
[Pages 69799-69800]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 99-32332]


-----------------------------------------------------------------------

DEPARTMENT OF JUSTICE

Antitrust Division


Notice Pursuant to the National Cooperative Research and 
Production Act of 1993--Advanced Technology Program: Microfluidics 
Device for Diagnosis of Nosocomial Agents MeDiNA

    Notice is hereby given that, on July 7, 1999, pursuant to section 
6(a) of the National Cooperative Research and

[[Page 69800]]

Production Act of 1993, 15 U.S.C. 4301 et seq. (``the Act''), Motorola, 
Inc. Physical Sciences Research Laboratories, Motorola Labs has filed 
written notifications simultaneously with the Attorney General and the 
Federal Trade Commission disclosing (1) the identities of the parties 
and (2) the nature and objectives of the venture. The notifications 
were filed for the purpose of invoking the Act's provisions limiting 
the recovery of antitrust plaintiffs to actual damages under specified 
circumstances. Pursuant to section 6(b) of the Act, the identities of 
the parties are Motorola, Inc. Physical Sciences Research Laboratories, 
Motorola Labs, Tempe, AZ; CFD Research Corporation, Huntsville, AL; and 
Arizona State University, Tempe, AZ. The nature and objectives of the 
venture are to conduct research under a program entitled 
``Microfluidics Device for Diagnosis of Nosocomial Agents MeDiNA''. The 
activities of this Joint Venture may be partially funded by an award 
from the Advanced Technology Program, National Institute of Standards 
and Technology, Department of Commerce.
Constance K. Robinson,
Director of Operations, Antitrust Division.
[FR Doc. 99-32332 Filed 12-13-99; 8:45 am]
BILLING CODE 4410-11-M